Genome-wide hydroxymethylation tested using the HELP-GT assay shows redistribution in cancer
暂无分享,去创建一个
Amit Verma | John M. Greally | Samir Parekh | Maximilian Christopeit | A. Maitra | J. Greally | A. Verma | U. Steidl | S. Bhattacharyya | S. Parekh | Nathaniel R. Campbell | Masako Suzuki | L. Godley | T. Bhagat | A. Vasanthakumar | Sangeeta Nischal | Aparna Vasanthakumar | Yiting Yu | Anirban Maitra | Yiting Yu | Ulrich Steidl | Masako Suzuki | Sanchari Bhattacharyya | Nathaniel Campbell | Jozef Mazdo | Tushar D. Bhagat | Sangeeta Nischal | Lucy Godley | M. Christopeit | Jozef Mazdo | Sanchari Bhattacharyya
[1] Serban Nacu,et al. Fast and SNP-tolerant detection of complex variants and splicing in short reads , 2010, Bioinform..
[2] A. Feinberg,et al. Genome-wide methylation analysis of human colon cancer reveals similar hypo- and hypermethylation at conserved tissue-specific CpG island shores , 2008, Nature Genetics.
[3] Philipp Kapranov,et al. Genome-wide mapping of 5-hydroxymethylcytosine in embryonic stem cells , 2011, Nature.
[4] D. Gilliland,et al. Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies. , 2009, Blood.
[5] J. Eshleman,et al. Genome-Wide Analysis of Promoter Methylation Associated with Gene Expression Profile in Pancreatic Adenocarcinoma , 2011, Clinical Cancer Research.
[6] G. Parmigiani,et al. Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses , 2008, Science.
[7] Mark D. Robinson,et al. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data , 2009, Bioinform..
[8] D. Neuberg,et al. Clinical effect of point mutations in myelodysplastic syndromes. , 2011, The New England journal of medicine.
[9] O. Abdel-Wahab,et al. Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation. , 2011, Cancer cell.
[10] O. Abdel-Wahab,et al. TET family proteins and their role in stem cell differentiation and transformation. , 2011, Cell stem cell.
[11] G. Hon,et al. Base-Resolution Analysis of 5-Hydroxymethylcytosine in the Mammalian Genome , 2012, Cell.
[12] M. van de Rijn,et al. Genomic Profiling Identifies GATA6 as a Candidate Oncogene Amplified in Pancreatobiliary Cancer , 2008, PLoS genetics.
[13] C. Iacobuzio-Donahue,et al. Global 5-hydroxymethylcytosine content is significantly reduced in tissue stem/progenitor cell compartments and in human cancers , 2011, Oncotarget.
[14] G. Ming,et al. Hydroxylation of 5-Methylcytosine by TET1 Promotes Active DNA Demethylation in the Adult Brain , 2011, Cell.
[15] P. Jin,et al. Selective chemical labeling reveals the genome-wide distribution of 5-hydroxymethylcytosine , 2011, Nature Biotechnology.
[16] J. Greally,et al. Optimized design and data analysis of tag-based cytosine methylation assays , 2010, Genome Biology.
[17] L. Aravind,et al. Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2 , 2010, Nature.
[18] Reid F. Thompson,et al. Widespread Hypomethylation Occurs Early and Synergizes with Gene Amplification during Esophageal Carcinogenesis , 2011, PLoS genetics.
[19] S. Balasubramanian,et al. Quantitative Sequencing of 5-Methylcytosine and 5-Hydroxymethylcytosine at Single-Base Resolution , 2012, Science.
[20] S. Jacobsen,et al. Tissue-specific Distribution and Dynamic Changes of 5-Hydroxymethylcytosine in Mammalian Genomes* , 2011, The Journal of Biological Chemistry.
[21] David R. Liu,et al. Conversion of 5-Methylcytosine to 5- Hydroxymethylcytosine in Mammalian DNA by the MLL Partner TET1 , 2009 .
[22] J. Licht,et al. Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. , 2010, Cancer cell.